Cornerstone Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $265K | Sell |
2,471
-345
| -12% | -$37.1K | 0.02% | 544 |
|
2025
Q1 | $284K | Sell |
2,816
-590
| -17% | -$59.5K | 0.02% | 489 |
|
2024
Q4 | $304K | Buy |
3,406
+9
| +0.3% | +$804 | 0.02% | 464 |
|
2024
Q3 | $285K | Sell |
3,397
-165
| -5% | -$13.8K | 0.02% | 468 |
|
2024
Q2 | $274K | Hold |
3,562
| – | – | 0.02% | 452 |
|
2024
Q1 | $244K | Sell |
3,562
-120
| -3% | -$8.22K | 0.02% | 476 |
|
2023
Q4 | $213K | Sell |
3,682
-668
| -15% | -$38.6K | 0.02% | 488 |
|
2023
Q3 | $230K | Buy |
4,350
+257
| +6% | +$13.6K | 0.02% | 481 |
|
2023
Q2 | $221K | Sell |
4,093
-52
| -1% | -$2.81K | 0.02% | 466 |
|
2023
Q1 | $207K | Buy |
+4,145
| New | +$207K | 0.02% | 448 |
|
2021
Q4 | – | Sell |
-5,896
| Closed | -$256K | – | 501 |
|
2021
Q3 | $256K | Sell |
5,896
-299
| -5% | -$13K | 0.03% | 386 |
|
2021
Q2 | $265K | Buy |
+6,195
| New | +$265K | 0.03% | 384 |
|
2018
Q3 | – | Sell |
-6,829
| Closed | -$208K | – | 1308 |
|
2018
Q2 | $208K | Buy |
+6,829
| New | +$208K | ﹤0.01% | 1314 |
|